CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
Go back to CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results| (NASDAQ: CRSP) | Delayed: 54.78 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.78 | 52 Week High | $18.88 | |||
| Open | $54.78 | 52 Week Low | $13.75 | |||
| Day High | $54.78 | P/E | N/A | |||
| Day Low | $54.78 | EPS | $0.00 | |||
| Volume | 1,089 | |||||

